Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
University of Colorado, Denver · with National Institutes of Health (NIH) · NCT02192866
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 1–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 270
- US sites recruiting
- 1
- Study start
- February 2014
- Record last updated
- December 19, 2022
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies.
Samples will come from
- People signed up by the investigators at the University of Colorado Denver
- University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Benaroya Research Institute) where people have been treated for peanut allergies
- University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges.
Blood and health histories from the University of North Carolina, Massachusetts General Hospital, National Jewish Health, The Children's Hospital and the Immune Tolerance Network will not have personal information linked.
The specific aims of this experiment are
- Come up with a lab test that will predict how bad an allergic reaction will be to peanuts.
- Find out what part of a peanut causes allergic reactions.
- Come up with preventions that can block peanut allergies.
- Find the strongest proteins in walnuts.
Conditions: Peanut Allergies; Tree Nut Allergies; Other Food Allergies
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
This protocol is to draw blood for a variety of related studies of food allergy. For this reason, we will list each group of subjects and the inclusion criteria for that group.
- De-identified sera or plasma from patients who have undergone Oral ImmunoTherapy (OIT) for peanut allergy. These samples already exist.
- Inclusion criteria:
- patients have been enrolled in a controlled trial of OIT for peanuts, and had at least one oral challenge.
- Age 1-75.
- De-identified samples from patients who are undergoing clinically indicated food challenges for peanut allergy.
- Inclusion criteria:
- concern regarding possible allergy to peanuts,
- age 1-75,
- plan to undergo a clinically indicated challenge with peanuts.
- Patients with peanut allergy.
- Inclusion criteria:
- excellent history of a systemic reaction to peanuts,
- age 6-75.
- Patients with other food allergies (especially tree nuts).
- Inclusion criteria:
- excellent history of a systemic reaction to tree nuts or other foods,
- age 6-75.
- Normal controls.
- Inclusion criteria:
- no known food allergies,
- recent ingestion of peanuts without difficulty, and
- age 6-75.
Exclusion Criteria
- Any known significant medical or psychiatric diagnosis
- Use of an investigational drug within 30 days
- Use of omalizumab (anti-IgE; Xolair) within 6 months
Recruiting US locations
University of Colorado School of Medicine
Denver, CO 80045
Site contact: Stephen C Dreskin · 303-877-2754 · stephen.dreskin@cuanschutz.edu
Study contacts (from the official record)
- Stephen Dreskin, MD, PhD · 303-724-7190 · Stephen.Dreskin@ucdenver.edu
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100